Skip to content

Validation of EORTC CIPN20 module in Indian Languages (Hindi and Marathi)

Validation of EORTC CIPN20 module into Indian languages Hindi and Marathi for assessing Quality of Lifein chemotherapy induced peripheral neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/08/002939
Enrollment
20
Registered
2012-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Breast Cancer, Ovarian Cancer,Head and Neck Cancer under going chemotherapy

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Either of the following a. Patients of breast cancer who have recently completed or are undergoing adjuvant chemotherapy using an anthracycline-taxane regimen. b. Patients of epithelial ovarian cancer who have recently completed or are undergoing first-line taxane-platinum chemotherapy in the neoadjuvant or adjuvant setting. c. Patients of head and neck cancer who are undergoing first-line platinum and/or taxane based chemotherapy or have recently completed it. 2) Completed chemotherapy within 12 weeks of inclusion in the study 3) Patients with evidence of clinical neuropathy as judged by the treating physicians. 4) Literate patients who can read the translated questionnaires. 5) Age more than 18 years 6) Patients willing to participate in the Study.

Exclusion criteria

Exclusion criteria: Patients unable to complete the questionnaire

Design outcomes

Primary

MeasureTime frame
a) Difficult to answer b) Confusing c) Difficult to understand d) Upsetting/offensive and/or e) Whether the patient would have asked the question in a different way. Timepoint: 3 months

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactShruti Velaskar

Tata Memorial Hospital

velshruti@gmail.com9819623316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026